Application no. and date | 13790467.8 (espacenet) (Federated) (European Patent Register), 20130515 | Patent/reg. no. and date | DK/EP 2850104, 20180711 | Publication date | 20150325 | Priority no. and date | US 201261649110 P, 20120518, US 201313804227, 20130314 | EP pub. no. and date |
EP 2850104 20150325 | Effective date | | Applicant/owner | SEAGEN INC., 21823 30th Drive, S.E.
Bothell, WA 98021, US | Applicant ref. no. | V1808-046-DK | Inventor | SUTHERLAND, May Kung, 21823 30th Drive Southeast
Bothell, Washington 98021, US, RYAN, Maureen, 21823 30th Drive Southeast
Bothell, Washington 98021, US, SUSSMAN, Django, 21823 30th Drive Southeast
Bothell, Washington 98021, US, BURKE, Patrick, 21823 30th Drive Southeast
Bothell, Washington 98021, US, JEFFREY, Scott, 21823 30th Drive Southeast
Bothell, Washington 98021, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/551 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/68 (2017.01) , C07K 16/28 (2006.01) | Title | CD33-ANTISTOFFER OG ANVENDELSE HERAF TIL CANCERBEHANDLING | Int. application no. | US2013041209 | Int. publication no. | WO2013173496 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|